Management of incidental gallbladder cancer in the nationwide CAPBIL study
British Journal of Surgery · 2026
DOI: 10.1093/bjs/znag050 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Surgery, 2026. Verfasst von Jane McClements und 54 weiteren Autor:innen. Beteiligte Einrichtung: Department of HPB Surgery, Belfast Health and Social Care Trust, Belfast, UK. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, Cholecystectomy. Die Arbeit nennt 56 Literaturangaben. Gefördert von: AstraZeneca.
Abstract (Originalsprache)
Background
The primary aim of this study was to provide contemporary, real-world data on the management approaches and survival outcomes of patients with incidental gallbladder cancer (GBC) following cholecystectomy in the UK. The secondary aim was to identify prognostic factors associated with survival.
Methods
Patients diagnosed with incidental GBC following cholecystectomy between January 2014 and December 2022 across 24 centres were included. Data collected comprised demographics, treatment details, histopathological findings, and survival outcomes.
Results
During the study interval, 285 patients had incidental GBC. The median follow-up was 31 months, with 5-year disease-free survival (DFS) and overall survival (OS) of 41.5% and 45.1% respectively. Of the 193 patients (67.7%) who underwent liver resection, most (97.9%) underwent segment 4B/5 resection. Patients with incidental GBC who underwent liver resection had significantly improved DFS (51 versus 15 months, P < 0.001) and OS (72 versus 26 months, P < 0.001) compared with those who did not. In addition, patients who completed adjuvant chemotherapy had better DFS (35 versus 15 months, P = 0.021) and OS (47 versus 26 months, P = 0.009) compared with those who did not. On multivariable analysis, nodal metastases were independently associated with poorer DFS (HR 2.04 (95% c.i. 1.30 to 3.20), P = 0.002), while advanced tumour (T3–T4) stage (HR 1.70 (95% c.i. 1.04 to 2.77), P = 0.034) and nodal metastases (HR 2.15 (95% c.i. 1.33 to 3.48), P = 0.002) predicted poorer OS.
Conclusion
Patients who underwent liver resection after incidental GBC had significantly better survival than those who did not proceed to further surgery. Adverse tumour biology was associated with poorer survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of HPB Surgery, Belfast Health and Social Care Trust, Belfast, UK.
- Department of Hepatobiliary and Pancreatic Surgery, Nottingham University Hospitals NHS Trust, Nottingham, UK.
- Department of HPB Surgery, Royal Surrey Hospital, London, UK.
- Department of HPB Surgery, Royal Free London NHS Foundation Trust, London, UK.
- Department of HPB Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
- Department of HPB Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
ORCID-Profile: Amanda Koh, Harivinthan Sellappan, Dimitrios Karavias, James Skipworth, Nicola Colucci, Mohamed Bekheit, Christopher Brown, Tareq Alsaoudi, Dhanwant Gomez
Förderung
- AstraZeneca
Zitieren
APA
McClements, J., Lee, W. T., Koh, A., Sellappan, H., Blackburn, L., Brooks, A., Nixon, G., Merali, N., Frampton, A., Safavi, D., Davidson, B., Feretis, M., Dasari, B. V. M., Chin, S. L., Karavias, D., Rowcroft, A., Lucocq, J., Harrison, E. M., Morrison-Jones, V., …, & UK HPB Research Collaborative Group (2026). Management of incidental gallbladder cancer in the nationwide CAPBIL study. British Journal of Surgery. https://doi.org/10.1093/bjs/znag050
Vancouver
McClements J, Lee WT, Koh A, Sellappan H, Blackburn L, Brooks A, et al. Management of incidental gallbladder cancer in the nationwide CAPBIL study. British Journal of Surgery. 2026. doi:10.1093/bjs/znag050
BibTeX
@article{McClements2026,
author = {McClements, Jane and Lee, Wan T and Koh, Amanda and Sellappan, Harivinthan and Blackburn, Lauren and Brooks, Adam and Nixon, Gemma and Merali, Nabeel and Frampton, Adam and Safavi, Danial and Davidson, Brian and Feretis, Michael and Dasari, Bobby V M and Chin, Sirr L and Karavias, Dimitrios and Rowcroft, Alistair and Lucocq, James and Harrison, Ewen M and Morrison-Jones, Victoria and Welsh, Fenella and Pathanki, Adithya and Marangoni, Gabriele and Bruno, Paris and Skipworth, James and Colucci, Nicola and Kosmoliaptsis, Vasilis and O'Leary, Lawrence and Malik, Hassan and Hamadalnile, Albasheer and Menon, Krishna and Patel, Waqqas and Bekheit, Mohamed and Tanno, Lulu and Silva, Michael and Brown, Christopher and Kumar, Nagappan and Triance, Joel and Shah, Nehal and Alsaoudi, Tareq and Bhardwaj, Neil and Nassar, Hussein and Mownah, Omar and Yeung, Derek and Bhogal, Ricky and Blanco-Colino, Ruth and Farid, Shahid and Aljaberi, Rami and Pandanaboyana, Sanjay and Abdelmohsin, Omar and Aroori, Somaiah and Evans, Daisy and Athwal, Tejinderjit and Lodge, J Peter A and Gomez, Dhanwant and UK HPB Research Collaborative Group, UK HPB Research Collaborative Group},
title = {Management of incidental gallbladder cancer in the nationwide CAPBIL study},
journal = {British Journal of Surgery},
year = {2026},
doi = {10.1093/bjs/znag050}
}
EUVIMED